The expression of classical nuclear DAMPs, including HMGB1 and HSP90, was upregulated in BTZ-treated colorectal cancer cells and more significantly in B-Myb–deficient cells in vitro and in vivo (Fig. S8). This evidence concerns the gene MYBL2 and colorectal cancer.